Actively Recruiting
Feasibility Performance Study of ABL90 FLEX PLUS HEM
Led by Radiometer Medical ApS · Updated on 2026-01-15
95
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
Sponsors
R
Radiometer Medical ApS
Lead Sponsor
B
Bispebjerg Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.
CONDITIONS
Official Title
Feasibility Performance Study of ABL90 FLEX PLUS HEM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject must be 18 years of age or older
- Informed consent is obtained directly from the subject or from their legally designated representative if the subject is temporarily incapacitated
- Subject is evaluated as suitable for the study by the principal investigator or designee
You will not qualify if you...
- Sample collection is considered by the principal investigator or designee to impose unnecessary risk to the subject
- Subject has invalid written informed consent or has withdrawn consent
- Subject is known to be pregnant or is breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bispebjerg Hospital
Copenhagen, NV, Denmark, 2400
Actively Recruiting
Research Team
V
Vadim Fedulov
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here